Comparison of the Efficacy of PENG Block in Combination With LFCN Block and Wound Infiltration
NCT ID: NCT04681222
Last Updated: 2020-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2019-01-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LFCN
Patients received LFCN + PENG blocks
LFCN
LFCN block was performed in combination with PENG block
Wound Infiltration
Patients received wound infiltration + PENG blocks
Wound infiltration
Wound infiltration was performed in combination with PENG block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LFCN
LFCN block was performed in combination with PENG block
Wound infiltration
Wound infiltration was performed in combination with PENG block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Total hip replacement
* Patients agreed to receive PENG block
* LFCN or wound infiltration performed combined with PENG blocks
Exclusion Criteria
* Total hip replacement performed for other indications
* Patients refused to receive PENG block
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bursa Yuksek Ihtisas Training and Research Hospital
OTHER_GOV
Derince Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hande Gurbuz
Medical Doctor, Associate Professor, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Derince Training and Research Hospital
Kocaeli, Derince, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.
Roy R, Agarwal G, Pradhan C, Kuanar D. Total postoperative analgesia for hip surgeries, PENG block with LFCN block. Reg Anesth Pain Med. 2019 Mar 28:rapm-2019-100454. doi: 10.1136/rapm-2019-100454. Online ahead of print. No abstract available.
Nersesjan M, Hagi-Pedersen D, Andersen JH, Mathiesen O, Dahl JB, Broeng L, Thybo KH. Sensory distribution of the lateral femoral cutaneous nerve block - a randomised, blinded trial. Acta Anaesthesiol Scand. 2018 Jul;62(6):863-873. doi: 10.1111/aas.13091. Epub 2018 Feb 21.
Giron-Arango L, Roques V, Peng P. Reply To Dr Roy et al: Total postoperative analgesia for hip surgeries: PENG block with LFCN block. Reg Anesth Pain Med. 2019 Mar 28:rapm-2019-100505. doi: 10.1136/rapm-2019-100505. Online ahead of print. No abstract available.
Mistry T, Sonawane KB, Kuppusamy E. PENG block: points to ponder. Reg Anesth Pain Med. 2019 Mar;44(3):423-424. doi: 10.1136/rapm-2018-100327. Epub 2019 Jan 11. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1262-9877
Identifier Type: -
Identifier Source: org_study_id